BMO Capital analyst Ambrish Srivastava maintains NVIDIA (NASDAQ:NVDA) with a Outperform and lowers the price target from $250 to $230.
TC BioPharm Announces Grant Funding In Collaboration With Queen Mary University Of London
TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, is proud to
